| Product Code: ETC12463477 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Imatinib Drug Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Imatinib Drug Market - Industry Life Cycle |
3.4 Latvia Imatinib Drug Market - Porter's Five Forces |
3.5 Latvia Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Latvia Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Latvia Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Latvia Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Latvia Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Latvia |
4.2.2 Growing awareness about the effectiveness of imatinib in treating CML |
4.2.3 Government initiatives to improve access to essential medications |
4.3 Market Restraints |
4.3.1 High cost of imatinib treatment |
4.3.2 Stringent regulations and approval processes for pharmaceutical products in Latvia |
5 Latvia Imatinib Drug Market Trends |
6 Latvia Imatinib Drug Market, By Types |
6.1 Latvia Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Latvia Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Latvia Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Latvia Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Latvia Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Latvia Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Latvia Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Latvia Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Latvia Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Latvia Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Latvia Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Latvia Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Latvia Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Latvia Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Latvia Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Latvia Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Latvia Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Latvia Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Latvia Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Latvia Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Latvia Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Latvia Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Latvia Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Latvia Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Latvia Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Latvia Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Latvia Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Latvia Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Latvia Imatinib Drug Market Import-Export Trade Statistics |
7.1 Latvia Imatinib Drug Market Export to Major Countries |
7.2 Latvia Imatinib Drug Market Imports from Major Countries |
8 Latvia Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare providers trained in prescribing imatinib |
8.3 Percentage of health insurance coverage for imatinib treatment |
9 Latvia Imatinib Drug Market - Opportunity Assessment |
9.1 Latvia Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Latvia Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Latvia Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Latvia Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Latvia Imatinib Drug Market - Competitive Landscape |
10.1 Latvia Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Latvia Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here